Brand · Tablet · Updated Nov 11, 2026
Trexall 5 mg tablet price what pharmacies pay, and what you should
Is my price fair?
Check the price you were quoted
Type what the pharmacy asked for trexall 5 mg tablet and see the markup over what they pay.
A benchmark from public data, not a price offer or medical advice. Prices vary by pharmacy, insurance and discount programs.
Trexall 5 mg price history
What pharmacies pay for 30 tablets, weekly- Now
- $722.65
- 52-week low
- $660.56
- 52-week high
- $722.65
- A year ago
- $660.56
Why the price changed
| Effective | Before | After | Change | Reason |
|---|---|---|---|---|
| Jan 1, 2026 | $22.02 | $24.09 | +9.4% | WAC Adjustment |
Prices per tablet. Reasons are the ones the national survey gives: a survey rate change comes from pharmacies' own invoices; a published price change follows the maker's list price.
What people paid for trexall 5 mg tablet
What did your pharmacy charge? It takes 30 seconds, it's anonymous - and it shows everyone which pharmacies are fair.
Supply status: shortages & recalls
Shortages
- Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) (NDC 61703-350-38)
- Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-408-25)
- Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) Multiple Dose Vial PREMIERProRx (NDC 61703-161-05)Next Delivery: July 2027; Estimated Recovery: September 2027; Shortage per Manufacturer: Manufacturing Delay
- Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-408-41)
- Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-124-40)
- Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) (NDC 61703-350-10)
- Methotrexate Sodium, Injection, 25 mg/1 mL (NDC 63323-123-10)Check wholesaler for inventory
- Methotrexate Preservative Free, Injection, 1 g (NDC 63323-122-50)Check wholesaler for inventory
- Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-35)Short dated inventory with expiry of 8/31/2027 available; Estimated recovery: Jan 2027
- Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3678-01)Estimated recovery: TBD
- Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-30)
- Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3671-01)Estimated recovery: TBD
In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.
Recalls
Showing the 6 most relevant of 14 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
Every manufacturer and package code
1 company sell trexall 5 mg tablet under 1 package code (NDC).
| Maker | Package codes | Per unit |
|---|---|---|
| Teva Women's Health LLC | 51285-366-01 | $24.09 |
All 1 package codes
A dash means no weekly price for that maker's packages. Which maker your pharmacy stocks usually doesn't change what you pay, but you can ask.
Questions to ask your pharmacist
- "What is your cash price, without insurance?" For low-cost generics it can be less than a copay.
- "Is a 90-day supply cheaper per tablet?" Dispensing fees are charged per fill, so fewer fills often cost less.
- "Do you match other pharmacies or accept discount cards?" Many do, if you ask.
These are questions, not advice. Never change how you take a medicine without talking to your prescriber or pharmacist.
Other trexall strengths and forms
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 7.5 mg tablet Brand | $36.21 | $1,086.27 / 30 tablets |
| 10 mg tablet Brand | $48.15 | $1,444.43 / 30 tablets |
Official label & what changed
These highlights do not include all the information needed to use TREXALL® safely and effectively. See full prescribing information for TREXALL.TREXALL® (methotrexate tablets), for oral use Initial U.S. Approval: 1953
WARNING: EMBRYO-FETAL TOXICITY, HYPERSENSITIVITY REACTIONS, SEVERE ADVERSE REACTIONS, AND RISK OF MEDICATION ERRORS
Methotrexate tablets can cause embryo-fetal toxicity, including fetal death. For non-neoplastic diseases, methotrexate tablets are contraindicated in pregnancy. For neoplastic diseases, advise females and males of reproductive potential to use effective contraception [see Contraindications (4), Warnings and Precautions (5.1), Use in Specific Populations (8.1, 8.3)].
Methotrexate tablets are contraindicated in patients with a history of severe hypersensitivity reactions to methotrexate, including anaphylaxis [Contraindications (4), Warnings and Precautions (5.2)].
Serious adverse reactions, including death, have been reported with methotrexate. Closely monitor for adverse reactions of the bone marrow, gastrointestinal tract, liver, lungs, skin, and kidneys. Withhold or discontinue methotrexate tablets as appropriate [Warnings and Precautions (5.3, 5.4, 5.5, 5.6, 5.7, 5.8)].
Methotrexate tablets when inadvertently administered once daily have resulted in death [Warnings and Precautions (5.9)].
WARNING: EMBRYO-FETAL TOXICITY, HYPERSENSITIVITY REACTIONS, SEVERE ADVERSE REACTIONS, and RISK OF MEDICATION ERRORS
See full prescribing information for complete boxed warning.
Methotrexate tablets can cause embryo-fetal toxicity, including fetal death. For non-neoplastic diseases, methotrexate tablets are contraindicated in pregnancy. For neoplastic diseases, advise patients of reproductive potential of the potential risk to a fetus and to use effective contraception (4, 5.1, 8.1, 8.3).
Methotrexate tablets are contraindicated in patients with a history of severe hypersensitivity reactions to methotrexate, including anaphylaxis (4, 5.2).
Serious adverse reactions, including death, have been reported with methotrexate. Closely monitor for adverse reactions of the bone marrow, gastrointestinal tract, liver, lungs, skin, and kidneys. Withhold or discontinue methotrexate tablets as appropriate (5.3, 5.4, 5.5, 5.6, 5.7, 5.8).
Methotrexate tablets when inadvertently administered once daily have resulted in death (5.9).
Recent major changes (as listed on the label)
Boxed Warning 05/2026
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Questions about trexall 5 mg tablet
How much does trexall 5 mg tablet cost without insurance?
Pharmacies pay about $722.65 for 30 tablets ($24.09 per tablet) as of November 11, 2026. A fair cash price is about $841.55: that cost plus a 15% margin and a $10.50 dispensing fee. Online cost-plus pharmacies charge around $841.05 including shipping.
Is my price for trexall 5 mg tablet fair?
Compare it with the fair cash price of $841.55 for 30 tablets. Up to about $1,051.94 is fair; above $1,683.10 is high, and worth asking the pharmacy for its cash price or trying another pharmacy. Check your quote.
Is trexall 5 mg tablet getting more expensive?
Over the last four weeks the price pharmacies pay held steady. Over a year it rose 9.4%. See the 52-week chart.
Who makes trexall 5 mg tablet?
1 company: Teva Women's Health LLC. See every package code.
Is trexall in shortage?
Yes - 15 products are listed as short or being discontinued. Details.
Has trexall been recalled?
14 recalls on record. Recalls name specific lots - check yours.
What does "pharmacies pay" mean?
It's the national average price retail pharmacies pay wholesalers and makers to buy the drug, from a weekly government survey of pharmacy invoices. It doesn't include the pharmacy's costs of filling a prescription, which is why the fair price adds a margin and a dispensing fee. How we work it out.
Talk about trexall 5 mg tablet
No comments yet. Questions, tips, what worked for you - start the conversation.